Pfizer Limited has scheduled a board meeting for February 9, 2026, to consider and approve the unaudited financial results for the quarter and nine months ended December 31, 2025. The trading window for company shares has been closed since December 31, 2025, and will remain closed until 48 hours after the results are made public.
Board Meeting Announcement
Pfizer Limited will hold a board meeting on February 9, 2026, to review and approve the company’s unaudited financial results. The results pertain to the quarter and nine months ending on December 31, 2025.
Trading Window Closure
In accordance with regulations regarding insider trading, Pfizer Limited has implemented a trading window closure. This restriction, which began on December 31, 2025, prohibits company insiders from trading shares. The trading window will remain closed until 48 hours after the unaudited financial results are officially disclosed on February 9, 2026.
Source: BSE
